viral
infect
implic
pathogenesi
multipl
sclerosi
epsteinbarr
viru
ebv
frequent
investig
possibl
candid
torqu
teno
viru
ttv
also
discuss
context
nevertheless
mechanist
aspect
remain
unresolv
report
viral
replic
measur
genom
amplif
well
quantit
pcr
two
isol
isol
multipl
sclerosi
brain
seri
ebvposit
neg
lymphoblastoid
burkitt
lymphoma
cell
line
result
demonstr
replic
transfect
ttv
genom
day
post
transfect
evalu
cell
line
quantit
amplif
indic
statist
signific
enhanc
ttv
replic
ebvposit
cell
line
includ
ebvconvert
bjab
line
comparison
ebvneg
burkitt
lymphoma
cell
line
bjab
suggest
helper
effect
ebv
infect
replic
ttv
present
studi
provid
inform
possibl
interact
ebv
ttv
etiolog
progress
multipl
sclerosi
pathogenesi
multipl
sclerosi
ms
probabl
trigger
combin
genet
environment
factor
frequent
childhood
infect
lower
socioeconom
statu
higher
sibl
exposur
lead
lower
ms
preval
remark
similar
observ
made
childhood
leukemia
children
experienc
viral
infect
later
life
risk
develop
diseas
sensit
detect
method
enabl
earlier
recognit
pediatr
ms
lead
estim
case
develop
age
year
diseas
even
diagnos
children
year
age
sever
virus
consid
involv
morbilliand
coronavirus
similar
theiler
murin
encephalomyel
viru
tmev
mice
induc
demyelin
diseas
natur
host
jc
polyomaviru
also
propos
present
consid
bystand
ms
number
herpesvirus
investig
etiolog
factor
ms
activ
varicella
zoster
viru
vzv
demonstr
exacerb
upregul
endogen
retrovirus
hervh
hervw
transcript
mediat
herpesvirus
herp
human
vzv
direct
role
ms
suspect
subsequ
question
differ
observ
preval
case
control
although
possibl
role
prior
onset
diseas
exclud
glycoprotein
express
surfac
infect
lymphocyt
allow
fusion
oligodendrocyt
astrocyt
express
receptor
necessari
viral
entri
crossreact
myelin
also
report
individu
histori
ebvinduc
infecti
mononucleosi
increas
risk
develop
ms
contrast
risk
extrem
low
ebvneg
individu
elev
ebv
antibodi
titr
associ
onset
ms
cours
diseas
whether
activ
ebv
infect
actual
play
role
ongo
ms
diseas
controversi
mechanist
aspect
ebv
infect
may
particip
pathogenesi
ms
also
remain
elus
despit
compel
epidemiolog
data
avail
infectioninduc
molecular
mimicri
implic
sever
autoimmun
diseas
includ
ms
lymphocyt
respond
latent
ebv
nuclear
increas
patient
ms
cross
react
myelin
antigen
previou
studi
demonstr
respons
clonal
expand
cell
isol
ms
patient
polyarginin
motif
present
open
read
frame
certain
torqu
teno
viru
ttv
type
serum
sampl
patient
taken
exacerb
month
later
harbour
ttv
dna
sequenc
addit
demonstr
ttv
dna
brain
sampl
ms
brain
one
enceph
brain
diseaseinduc
potenti
ttv
mechan
involv
replic
understood
ttv
first
identifi
japanes
patient
suffer
posttransfus
hepat
unknown
etiolog
multitud
ttv
genotyp
mark
genet
heterogen
subsequ
identifi
primari
infect
occur
earli
life
children
infect
least
ttv
type
month
age
year
age
genom
divers
ubiquit
preval
pose
main
obstacl
attempt
defin
role
tt
virus
pathogenesi
diseas
ttv
dna
demonstr
mani
organ
tissu
peripher
blood
act
reservoir
tt
virus
replic
viral
dna
demonstr
bone
marrow
cell
liver
report
implic
ttv
infect
autoimmun
diseas
influenc
hostdepend
factor
genotyp
predilect
environment
trigger
longterm
replic
tt
virus
investig
short
term
replic
transcript
describ
cell
line
divers
origin
recent
report
longterm
replic
tt
virus
concomit
format
independ
replic
subvir
mttv
consist
mother
genom
evidenc
intracellular
virallik
particl
format
day
transfect
fulllength
genom
hodgkin
lymphoma
cell
line
studi
past
concentr
singl
viru
infect
etiolog
factor
ms
wherea
interact
virus
pathogenesi
approach
herpesvirus
known
induc
amplif
viral
genom
well
cellular
sequenc
enhanc
replic
hepat
c
viru
hcv
current
studi
analys
question
whether
ebv
stimul
induc
ttv
replic
vitro
isol
seri
fulllength
ttv
genom
diseas
brain
ms
patient
transfect
two
ttv
isol
ebvcarri
cell
line
two
ebvneg
cell
line
use
control
quantit
pcr
analys
clearli
demonstr
helper
effect
ebv
replic
ttv
genom
result
provid
addit
inform
link
viral
infect
pathogenesi
ms
subsequ
demonstr
helperdepend
longterm
replic
propag
ttv
isol
cell
line
harbour
larg
tantigen
present
studi
analys
whether
ebv
also
abl
exert
helper
function
replic
ttv
includ
burkitt
lymphoma
cell
line
posit
bjabebv
ramosebv
neg
ebv
bjab
ramo
ebvimmort
b
cell
line
ms
patient
ebvproduc
b
cell
line
replic
ttvhd
dna
confirm
test
cell
line
long
distanc
pcr
total
cellular
dna
long
distanc
pcr
perform
use
backtoback
primer
specif
amplifi
fulllength
genom
exampl
present
figur
result
compar
replic
measur
day
transfect
cell
line
replic
also
confirm
electron
microscopi
figur
demonstr
viru
replic
transfect
genom
ebvposit
neg
cell
line
quantifi
level
ttv
replic
realtim
pcr
viral
dna
normal
housekeep
gene
hmb
rel
quantif
calcul
use
ebvneg
cell
line
bjab
calibr
measur
perform
time
point
cell
harvest
use
two
independ
primer
set
per
isol
detect
two
isol
includ
studi
order
avoid
possibl
variat
may
result
differ
ttv
genom
organ
primer
probe
list
tabl
quantit
analys
perform
one
set
primer
probe
shown
figur
b
overal
ttvhd
replic
increas
day
cell
line
test
compar
viral
replic
bjab
compar
result
obtain
second
primer
pair
probe
select
studi
data
shown
similar
pattern
amplif
obtain
differ
biolog
replic
untransfect
control
nontempl
control
sampl
remain
neg
experi
presenc
ebv
cell
line
bjabebv
ramosebv
result
elev
level
dna
replic
replic
isol
significantli
higher
cell
line
compar
bjab
time
point
evalu
figur
day
onward
higher
level
replic
figur
note
bjab
cell
line
convert
ebvposit
cell
line
viral
level
seem
increas
earli
transfect
level
replic
versu
vari
significantli
cell
type
except
day
transfect
replic
differ
isol
ramosebv
statist
signific
well
day
replic
two
ttv
isol
differ
significantli
replic
ebvimmort
b
cell
ms
patient
figur
seem
stabl
time
comparison
decreas
replic
cell
initi
increas
decreas
rapidli
ttv
replic
behaviour
ebvposit
ramosebv
cell
line
surpris
increas
replic
ramosebv
versu
ramo
cell
statist
signific
day
replic
ramo
cell
exceed
ramosebv
cell
day
replic
ramosebv
cell
increas
day
day
level
reach
statist
signific
day
day
replic
day
similar
isol
higher
replic
ramo
ramosebv
cell
previou
report
detect
differ
level
permiss
infect
ramo
ebvconvert
ramosebv
cell
enhanc
replic
presenc
ebv
independ
ebv
copi
number
measur
vari
level
ttv
replic
respect
ebv
posit
cell
line
quantifi
ebv
dna
determin
whether
ebv
copi
number
exert
influenc
realtim
quantit
pcr
perform
time
point
day
post
transfect
cultur
transfect
ttv
genom
use
dna
ebvharbour
copiescel
cell
line
namalwa
standard
curv
repres
exampl
ebv
copi
numbercel
day
posttransfect
present
figur
ebv
copi
number
cell
line
copiescel
wherea
cell
harbour
ebv
copiescel
interestingli
bjabebv
cell
habor
ebv
copiescel
despit
high
level
ttv
amplif
lowest
ebv
copi
number
found
ramosebv
contain
ebv
copiescel
analysi
conclud
although
presenc
ebv
seem
enhanc
replic
ttvhd
dna
ebv
viral
copi
number
reflect
differ
replic
level
cell
line
ebv
product
measur
express
consist
ebv
copi
number
correl
ttv
replic
quantif
ebv
dna
genom
provid
inform
regard
intracellular
activ
ebv
dna
wellcharacter
cell
line
ebv
product
report
wherea
ebv
viral
capsid
antigen
vca
synthesi
demonstr
bjabebv
cell
line
actual
activ
ebv
dna
less
clear
ramosebv
cell
line
unknown
cell
line
therefor
quantifi
ebv
envelop
glycoprotein
mrna
marker
ebv
lytic
activ
ebv
posit
cell
line
use
studi
result
obtain
show
similar
pattern
ebv
genom
quantif
comparison
ebv
dna
copi
number
rna
quantif
present
figur
repres
day
transfect
show
highest
copi
number
ng
total
cellular
rna
respect
figur
cell
harbour
ng
rna
follow
bjabebv
ramosebv
ng
total
rna
respect
consist
result
obtain
ttv
isol
differ
biolog
replic
thu
ebv
replic
measur
gene
transcript
ebvposit
cell
line
use
studi
product
necessarili
relat
ebv
copi
numbercel
level
ebv
activ
howev
seem
influenc
level
ttvhd
replic
transfect
fulllength
genom
two
tt
virus
isol
brain
tissu
ms
patient
order
ascertain
first
whether
viral
replic
take
place
differ
b
lymphocyt
burkitt
lymphoma
cell
line
secondli
determin
whether
ebv
act
helper
viru
replic
ttv
result
present
demonstr
replic
day
posttransfect
overal
observ
replic
pattern
tt
virus
celltyp
depend
higher
level
replic
measur
ebv
posit
cell
line
show
variabl
ddct
certain
time
point
figur
number
studi
demonstr
abil
herpesvirus
induc
amplif
persist
viral
dna
sever
line
evid
may
indic
mechan
ebv
exert
helperfunct
ttv
replic
previou
studi
demonstr
requir
helperfunct
replic
propag
seri
ttv
isol
cell
line
construct
express
high
level
larg
tantigen
put
origin
replic
tt
virus
harbour
number
pentanucleotid
motif
similar
bind
site
larg
tantigen
requir
episom
mainten
ebv
dna
bind
origin
replic
sequencespecif
manner
cellular
transcript
gene
express
also
regul
bind
cellular
promot
analys
larg
number
promot
indic
differ
bind
motif
found
ebv
genom
cellular
genom
indic
notion
addit
yet
unidentifi
bind
site
cellular
promot
devoid
bind
site
may
even
upregul
mere
presenc
cell
enhanc
hcv
replic
via
transactiv
function
demonstr
addit
investig
need
clarifi
mechan
may
act
stimul
ttv
genom
select
sever
ebvposit
burkitt
lymphomaand
b
cell
line
order
evalu
replic
ebvposit
cell
line
contain
evidenc
quantit
measur
envelop
glycoprotein
mrna
marker
ebv
lytic
activ
figur
ttv
origin
replic
present
isol
use
present
studi
influenc
differ
viral
genom
studi
role
viru
infect
etiolog
multipl
sclerosi
repeatedli
investig
possibl
role
ttv
infect
autoimmun
diseas
includ
multipl
sclerosi
report
previous
role
ebv
infect
ms
howev
controversi
rang
failur
demonstr
presenc
demonstr
increas
risk
previou
ebv
infect
elev
ebv
antibodi
specif
antibodi
ms
patient
present
studi
associ
ttv
ebv
infect
lymphocyt
bcell
lymphoma
hodgkin
lymphoma
inconclus
increas
permiss
infect
herp
simplex
viru
first
hour
infect
demonstr
ebvconvert
previous
neg
burkitt
lymphoma
deriv
cell
line
therefor
presenc
ttv
ebv
b
cell
feasibl
naiv
memori
b
cell
equal
suscept
ebv
infect
ebv
infect
may
lead
ebv
persist
b
cell
provid
ground
differenti
ebvlat
infect
circul
memori
b
cell
ectop
folliclelik
structur
harbour
b
cell
similar
found
organspecif
immun
diseas
also
describ
cerebr
mening
ms
patient
persist
ebv
infect
measur
elev
antibodi
could
provid
fertil
field
induct
molecular
mimicri
propos
autoreact
cell
induc
molecular
mimicri
may
need
fertil
field
persist
viral
infect
becom
autoaggress
vivo
clonal
expand
cell
isol
cerebrospin
fluid
ms
patient
respond
polyarginin
motif
present
tt
virus
isol
use
present
studi
isol
ms
brain
tissu
put
protein
gene
transcript
mttv
share
similar
suffici
modifi
signatur
motif
cellular
gene
includ
myelin
basic
protein
mbp
unpublish
result
number
studi
indic
elev
myelin
specif
cell
popul
ms
patient
propos
follow
model
role
ebv
ttv
infect
etiolog
agent
ms
simultan
infect
either
ttv
mttv
ebvinfect
memori
b
cell
lead
persist
ttv
support
express
spontan
activ
ebv
lytic
cycl
cell
could
result
burst
ttv
mttv
express
product
infect
neighbour
cell
ttv
autoimmunereact
epitop
turn
induc
autoreact
cell
react
specif
protein
ttvinfect
cell
model
could
explain
local
autoimmun
respons
focal
natur
ms
lesion
reemerg
new
foci
demonstr
ebvhelp
depend
activ
isol
ms
brain
tissu
ongo
studi
investig
crossreact
express
protein
myelin
immun
respons
seven
hematopoiet
cell
line
either
ebvposit
ebvneg
select
studi
burkitt
lymphoma
cell
line
includ
bjab
ramo
ebvneg
harbor
ebv
genom
ebv
nuclear
delet
comparison
includ
bjab
ramo
cell
line
previous
convert
ebvposit
infect
ebv
genom
origin
cell
line
bjabebv
ramosebv
addit
two
b
cell
line
includ
human
ebvimmort
b
cell
line
establish
ms
patient
kind
gift
sospedra
ebvproduc
cottontop
marmoset
cell
line
ebv
dna
quantifi
use
serial
dilut
namalwa
dna
human
burkitt
lymphoma
cell
line
contain
ebv
genom
copi
per
cell
kindli
provid
regina
feederl
refer
standard
curv
cell
line
mycoplasma
free
confirm
pcr
maintain
rpmi
medium
supplement
fetal
calf
serum
penicillinstreptomycin
co
thirti
fulllength
ttv
genom
isol
laboratori
brain
sampl
major
differ
genom
organ
describ
virus
reason
consequ
rearrang
tt
virus
date
known
therefor
select
fulllength
genom
origin
one
brain
sampl
transfect
assay
access
number
fuse
last
nt
part
control
region
wherea
acc
fuse
viral
genom
releas
vector
construct
invitrogen
purifi
separ
gel
electrophoresi
peqlab
biotechnolog
prior
transfect
cell
transfect
mg
ttvdna
cell
perform
use
electropor
nucleofector
ii
transfect
devic
amaxa
biosystem
nucleotransfect
kit
v
cat
amaxa
biosystem
follow
protocol
recommend
manufactur
respect
cell
type
transfect
effici
control
parallel
transfect
plasmid
pmaxgfp
amaxa
biosystem
neg
control
cell
line
without
nucleofector
solut
includ
cell
transfect
harvest
day
wherea
transfect
cell
harvest
day
passag
transfect
cultur
day
respect
cell
passag
day
interv
fresh
medium
ad
cell
becam
dens
interv
transfect
assay
perform
parallel
us
sb
cw
cultur
harvest
day
transfect
averag
densiti
ml
total
dna
rna
isol
total
dna
extract
use
phenolchloroformisoamylalcohol
subject
dpni
fermenta
digest
remov
input
dna
use
transfect
total
rna
isol
transfect
cell
use
rneasi
mini
kit
qiagen
hilden
germani
rna
sampl
treat
dnasei
promega
remov
residu
dna
qualiti
rna
sampl
check
run
sampl
agaros
gel
order
investig
whether
replic
transfect
occur
test
cell
line
genom
dna
isol
transfect
cell
line
subject
longpcr
amplif
use
takara
la
taq
enzym
takara
bio
inc
backtoback
primer
specif
primer
use
individu
ttv
type
document
tabl
reaction
perform
follow
initi
denatur
min
follow
cycl
min
min
min
follow
final
elong
min
two
set
primer
respect
hydrolysi
probe
design
genom
region
span
nucleotid
ident
isol
primer
probe
obtain
biomersnet
two
set
separ
nucleotid
genom
dna
sampl
ng
ml
amplifi
triplic
total
volum
ml
contain
ml
taqman
univers
master
mix
appli
biosystem
ml
forward
primer
mm
ml
revers
primer
mm
ml
probe
mm
ml
water
reaction
mixtur
amplifi
cycl
min
initi
activ
dna
polymeras
min
fluoresc
signal
detect
abi
sequenc
detect
system
appli
biosystem
result
time
point
day
standard
amplif
ebvneg
bjab
cell
line
express
fold
chang
valu
dna
sampl
obtain
untransfect
cell
well
nontempl
control
ntc
includ
reaction
plate
data
normal
perform
use
hmb
hydroxymethylbilan
synthas
housekeep
gene
report
share
specif
human
cottontop
tamarin
cell
line
beacon
design
softwar
use
design
taqman
assay
hmb
select
homolog
region
human
cottontop
tamarin
genom
valid
primer
probe
assay
optim
perform
describ
previous
amplif
reaction
hmb
perform
ml
volum
contain
ml
taqman
univers
master
mix
appli
biosystem
forward
revers
primer
ml
mm
ml
probe
mm
ml
water
amplitaq
gold
dna
polymeras
activ
min
prior
amplif
cycl
min
fluoresc
signal
measur
ebv
dna
quantifi
target
gene
ebv
posit
cell
line
genom
dna
sampl
ng
triplic
use
reaction
ntc
includ
reaction
plate
primer
probe
use
detect
ebv
dna
list
tabl
quantif
ebv
dna
cell
line
calcul
standard
curv
gener
serial
dilut
namalwa
dna
copi
ebv
dna
per
cell
previous
describ
ebv
activityrepl
measur
quantifi
mrna
product
bp
fragment
ebv
envelop
glycoprotein
gene
primer
hydrolysi
probe
use
list
tabl
rna
sampl
ng
transfect
cell
amplifi
use
one
step
rtqpcr
protocol
appli
biosystem
briefli
rtqpcr
mixtur
contain
mml
taqman
fast
viru
master
mix
ml
forward
revers
primer
mm
ml
probe
mm
ml
water
ml
rna
initi
revers
transcript
step
min
follow
rt
inactivationiniti
denatur
reaction
mixtur
subsequ
amplifi
cycl
min
neg
control
includ
ntc
sampl
without
revers
transcriptas
fluoresc
signal
detect
use
abi
sequenc
detect
system
appli
biosystem
ebv
gene
express
quantifi
use
extern
rna
calibr
standard
gener
follow
ebv
late
envelop
glycoprotein
gene
transcrib
cellular
rna
superscript
ii
revers
transcriptas
invitrogen
use
specif
primer
contain
restrict
site
bamhi
ecori
tabl
result
bp
cdna
amplicon
clone
vector
trancript
kit
roch
describ
previous
sequenc
analysi
verifi
sequenc
cdnacontain
plasmid
linear
ecori
prior
subsequ
vitro
transcript
use
rna
polymeras
trancript
kit
roch
size
qualiti
transcript
determin
denatur
rna
electrophoresi
serial
dilut
bp
transcript
ng
bjab
rna
ebv
neg
dnasernas
free
water
use
calibr
ebv
gene
express
standard
store
aliquot
longer
week
aliquot
use
amplif
bjab
cell
line
ebvneg
use
calibr
compar
ttv
amplif
cell
line
analys
mean
ddct
deriv
experi
confid
interv
mean
calcul
valu
convert
fold
chang
comparison
amplif
level
fold
chang
ramo
ebvneg
ramosebv
cell
line
perform
ttest
